FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1978513518> ?p ?o ?g. }

• W1978513518 endingPage "1208" @default.
• W1978513518 startingPage "1198" @default.
• W1978513518 abstract "Antimicrobial resistance among gram-positive organisms such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) continues to limit therapeutic options. The oxazolidinones are a synthetic class of agents now commonly relied on for the treatment of serious MRSA and VRE infections. With increasing utilization of linezolid, resistant pathogens have once again begun to emerge. Tedizolid, a next-generation oxazolidinone, possesses a spectrum of activity including MRSA and VRE, with significantly enhanced potency also against linezolid-resistant strains. Preclinical and early clinical studies have reported positive results, demonstrating a favorable pharmacokinetic profile in combination with key potential safety advantages. In two phase III clinical trials, tedizolid was found noninferior to linezolid in the treatment of acute bacterial skin and skin structure infections. Investigations for treatment of ventilator-acquired and health care–associated pneumonia are currently underway. Tedizolid has been subjected to pharmacodynamics studies throughout its development that have highlighted properties unique to this agent. Considerable accumulations in epithelial lining fluid and antimicrobial activity greatly augmented by the presence of granulocytes suggest that slow but bactericidal activity may be possible in some clinical scenarios. Structural distinctions between tedizolid and linezolid suggest that tedizolid has decreased vulnerability to oxazolidinone resistance mechanisms. Tedizolid minimum inhibitory concentrations are essentially unchanged in organisms possessing the chloramphenicol-florfenicol resistance gene, a horizontally transferable linezolid resistance mechanism. Although the clinical experience with tedizolid remains limited, early data suggest a potential role in the treatment of serious infections due to multidrug-resistant gram-positive pathogens." @default.
• W1978513518 created "2016-06-24" @default.
• W1978513518 creator A5007525527 @default.
• W1978513518 creator A5025843382 @default.
• W1978513518 creator A5043553812 @default.
• W1978513518 date "2014-09-30" @default.
• W1978513518 modified "2023-09-26" @default.
• W1978513518 title "Early Experience with Tedizolid: Clinical Efficacy, Pharmacodynamics, and Resistance" @default.
• W1978513518 cites W1958177082 @default.
• W1978513518 cites W1972821355 @default.
• W1978513518 cites W1974734033 @default.
• W1978513518 cites W1976210769 @default.
• W1978513518 cites W1981107394 @default.
• W1978513518 cites W1992574152 @default.
• W1978513518 cites W1993806447 @default.
• W1978513518 cites W2003136021 @default.
• W1978513518 cites W2030040211 @default.
• W1978513518 cites W2033143941 @default.
• W1978513518 cites W2036153776 @default.
• W1978513518 cites W2037702349 @default.
• W1978513518 cites W2047642255 @default.
• W1978513518 cites W2064227079 @default.
• W1978513518 cites W2073818453 @default.
• W1978513518 cites W2075038827 @default.
• W1978513518 cites W2099194418 @default.
• W1978513518 cites W2109090890 @default.
• W1978513518 cites W2109396161 @default.
• W1978513518 cites W2111723579 @default.
• W1978513518 cites W2114408864 @default.
• W1978513518 cites W2118059826 @default.
• W1978513518 cites W2120052193 @default.
• W1978513518 cites W2122389046 @default.
• W1978513518 cites W2128473831 @default.
• W1978513518 cites W2129881065 @default.
• W1978513518 cites W2135044274 @default.
• W1978513518 cites W2137610450 @default.
• W1978513518 cites W2142827309 @default.
• W1978513518 cites W2143399162 @default.
• W1978513518 cites W2145514220 @default.
• W1978513518 cites W2146190796 @default.
• W1978513518 cites W2150760368 @default.
• W1978513518 cites W2156076829 @default.
• W1978513518 cites W2156283731 @default.
• W1978513518 cites W2157041838 @default.
• W1978513518 cites W2160934143 @default.
• W1978513518 cites W2162370222 @default.
• W1978513518 cites W2166422764 @default.
• W1978513518 cites W2167594496 @default.
• W1978513518 cites W2171770556 @default.
• W1978513518 cites W2198367621 @default.
• W1978513518 cites W2321543931 @default.
• W1978513518 doi "https://doi.org/10.1002/phar.1491" @default.
• W1978513518 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25266820" @default.
• W1978513518 hasPublicationYear "2014" @default.
• W1978513518 type Work @default.
• W1978513518 sameAs 1978513518 @default.
• W1978513518 citedByCount "44" @default.
• W1978513518 countsByYear W19785135182014 @default.
• W1978513518 countsByYear W19785135182015 @default.
• W1978513518 countsByYear W19785135182016 @default.
• W1978513518 countsByYear W19785135182017 @default.
• W1978513518 countsByYear W19785135182018 @default.
• W1978513518 countsByYear W19785135182019 @default.
• W1978513518 countsByYear W19785135182020 @default.
• W1978513518 countsByYear W19785135182021 @default.
• W1978513518 countsByYear W19785135182022 @default.
• W1978513518 countsByYear W19785135182023 @default.
• W1978513518 crossrefType "journal-article" @default.
• W1978513518 hasAuthorship W1978513518A5007525527 @default.
• W1978513518 hasAuthorship W1978513518A5025843382 @default.
• W1978513518 hasAuthorship W1978513518A5043553812 @default.
• W1978513518 hasBestOaLocation W19785135181 @default.
• W1978513518 hasConcept C111113717 @default.
• W1978513518 hasConcept C112705442 @default.
• W1978513518 hasConcept C126322002 @default.
• W1978513518 hasConcept C2777052132 @default.
• W1978513518 hasConcept C2777914695 @default.
• W1978513518 hasConcept C2778980435 @default.
• W1978513518 hasConcept C2779489039 @default.
• W1978513518 hasConcept C2781414143 @default.
• W1978513518 hasConcept C4937899 @default.
• W1978513518 hasConcept C501593827 @default.
• W1978513518 hasConcept C523546767 @default.
• W1978513518 hasConcept C54355233 @default.
• W1978513518 hasConcept C71924100 @default.
• W1978513518 hasConcept C86803240 @default.
• W1978513518 hasConcept C89423630 @default.
• W1978513518 hasConcept C94665300 @default.
• W1978513518 hasConcept C98274493 @default.
• W1978513518 hasConceptScore W1978513518C111113717 @default.
• W1978513518 hasConceptScore W1978513518C112705442 @default.
• W1978513518 hasConceptScore W1978513518C126322002 @default.
• W1978513518 hasConceptScore W1978513518C2777052132 @default.
• W1978513518 hasConceptScore W1978513518C2777914695 @default.
• W1978513518 hasConceptScore W1978513518C2778980435 @default.
• W1978513518 hasConceptScore W1978513518C2779489039 @default.
• W1978513518 hasConceptScore W1978513518C2781414143 @default.
• W1978513518 hasConceptScore W1978513518C4937899 @default.

• next